跳至主要内容
临床试验/NCT00910533
NCT00910533Unknown不适用

Clinical and Microbiological Parameters in Patients With Early Lyme Neuroborreliosis

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Objective sequelae and post-treatment subjective symptoms in patients treated with ceftriaxone for early Lyme neuroborreliosis

研究概览

简要总结

The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • erythema migrans within 4 months before neurologic involvement and pleocytosis in patients >15 years old

排除标准

  • pregnancy
  • lactation
  • history of adverse reaction to a beta-lactam antibiotic

研究组 & 干预措施

Early Lyme neuroborreliosis patients

Active Comparator

干预措施: ceftriaxone (Drug)

结局指标

主要结局

Objective sequelae and post-treatment subjective symptoms in patients treated with ceftriaxone for early Lyme neuroborreliosis

时间窗: 1 year follow-up

次要结局

  • Comparison of subjective symptoms between patients treated with ceftriaxone for early Lyme neuroborreliosis and control subjects without a history of Lyme borreliosis(1 year follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Franc Strle

M.D., PhD

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验